Stryker Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Stryker is de winst gegroeid met een gemiddeld jaarlijks percentage van 11.2%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 13.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 9.3% per jaar. Het rendement op eigen vermogen van Stryker is 17.8%, en het heeft een nettomarge van 16.3%.

Belangrijke informatie

11.2%

Groei van de winst

10.8%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie	8.9%
Inkomstengroei	9.3%
Rendement op eigen vermogen	17.8%
Nettomarge	16.3%
Laatste winstupdate	30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06

Opbrengsten en kosten

Hoe Stryker geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NYSE:SYK Opbrengsten, kosten en inkomsten (USD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Sep 24	21,974	3,590	7,327	1,457
30 Jun 24	21,389	3,448	7,206	1,433
31 Mar 24	20,963	3,361	7,051	1,416
31 Dec 23	20,498	3,165	6,943	1,387
30 Sep 23	19,885	2,585	6,690	1,364
30 Jun 23	19,455	2,709	6,494	1,367
31 Mar 23	18,952	2,627	6,278	1,372
31 Dec 22	18,449	2,358	6,114	1,367
30 Sep 22	17,948	2,457	6,014	1,372
30 Jun 22	17,629	2,079	5,925	1,322
31 Mar 22	17,430	2,015	5,929	1,281
31 Dec 21	17,108	1,994	5,752	1,235
30 Sep 21	16,669	1,900	5,525	1,159
30 Jun 21	16,246	2,083	5,297	1,095
31 Mar 21	14,716	1,408	4,900	1,018
31 Dec 20	14,351	1,599	4,759	984
30 Sep 20	14,220	1,756	4,766	983
30 Jun 20	14,070	1,601	4,824	987
31 Mar 20	14,956	2,164	4,995	1,000
31 Dec 19	14,884	2,083	4,968	971
30 Sep 19	14,549	3,426	4,970	938
30 Jun 19	14,204	3,550	4,914	913
31 Mar 19	13,876	3,522	4,864	883
31 Dec 18	13,601	3,553	4,808	862
30 Sep 18	13,276	1,236	4,687	846
30 Jun 18	13,040	1,080	4,556	823
31 Mar 18	12,730	1,019	4,484	799
31 Dec 17	12,444	1,020	4,380	787
30 Sep 17	12,130	1,779	4,239	771
30 Jun 17	11,957	1,700	4,167	757
31 Mar 17	11,785	1,689	4,076	748
31 Dec 16	11,325	1,647	3,941	715
30 Sep 16	10,883	1,659	3,828	690
30 Jun 16	10,470	1,605	3,703	661
31 Mar 16	10,062	1,617	3,591	632
31 Dec 15	9,946	1,439	3,511	625
30 Sep 15	9,849	1,177	3,445	614
30 Jun 15	9,818	933	3,417	612
31 Mar 15	9,749	669	3,381	616
31 Dec 14	9,675	515	3,356	614
30 Sep 14	9,525	641	2,851	600
30 Jun 14	9,287	687	3,147	583
31 Mar 14	9,136	772	3,305	557
31 Dec 13	9,021	1,006	3,345	536

Kwaliteitswinsten: SYK heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (16.3%) SYK } zijn hoger dan vorig jaar (13%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van SYK is de afgelopen 5 jaar met 11.2% per jaar gegroeid.

Versnelling van de groei: De winstgroei van SYK over het afgelopen jaar ( 38.9% ) overtreft het 5-jarig gemiddelde ( 11.2% per jaar).

Winst versus industrie: De winstgroei SYK over het afgelopen jaar ( 38.9% ) overtrof de Medical Equipment -sector 12.2%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 17.8% ) van SYK wordt als laag beschouwd.

Stryker Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Recent updates

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Treace Medical Concepts, Inc. Files Lawsuit Against Stryker Corporation and Its Subsidiary Wright Medical Technology, Inc

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker Corporation (NYSE:SYK) completed the acquisition of Vertos Medical Inc.

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Independent Director notifies of intention to sell stock

Stryker Announces Launch of Pangea Plating System

Stryker: Wait For A Better Entry Point Post-Q2 Results

VP & CFO recently sold US$6.7m worth of stock

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

VP & CFO exercised options and sold US$3.7m worth of stock

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors

Stryker: Mako Shoulder And Spine Launches Are On The Way

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year